{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:44:36Z","timestamp":1790653476332,"version":"4.1.0"},"reference-count":118,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Plenty of non-cardiovascular drugs alter cardiac electrophysiology and may ultimately lead to life-threatening arrhythmias. In clinical practice, measuring the QT interval as a marker for the repolarization period is the most common tool to assess the electrophysiologic safety of drugs. However, the sole measurement of the QT interval may be insufficient to determine the proarrhythmic risk of non-cardiovascular agents. Several other markers are considered in pre-clinical safety testing to determine potential harm on cardiac electrophysiology. Besides measuring typical electrophysiologic parameters such as repolarization duration, whole-heart models allow the determination of potential predictors for proarrhythmia. Spatial and temporal heterogeneity as well as changes of shape of the action potential can be easily assessed. In addition, provocation manoeuvers (either by electrolyte imbalances or programmed pacing protocols) may induce sustained arrhythmias and thereby determine ventricular vulnerability to arrhythmias. Compared with the human heart, the rabbit heart possesses a similar distribution of ion currents that govern cardiac repolarization, resulting in a rectangular action potential configuration in both species. In addition, similar biophysical properties of rabbit and human cardiac ion channels lead to a comparable pharmacologic response in human and rabbit hearts. Of note, arrhythmia patterns resemble in both species due to the similar effective size of human and rabbit hearts. Thus, the rabbit heart is particularly suitable for testing the electrophysiologic safety of drugs. Several experimental setups have been developed for studying cardiac electrophysiology in rabbits, ranging from single cell to tissue preparations, whole-heart setups, and in vivo models.<\/jats:p>","DOI":"10.1093\/europace\/euaa288","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T19:12:23Z","timestamp":1598555543000},"page":"828-836","source":"Crossref","is-referenced-by-count":15,"title":["Role of the rabbit whole-heart model for electrophysiologic safety pharmacology of non-cardiovascular drugs"],"prefix":"10.1093","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9172-296X","authenticated-orcid":false,"given":"Christian","family":"Ellermann","sequence":"first","affiliation":[{"name":"Department of Cardiology II (Electrophysiology), University Hospital M\u00fcnster, Albert-Schweitzer-Campus 1, M\u00fcnster D-48149, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9344-7826","authenticated-orcid":false,"given":"Julian","family":"Wolfes","sequence":"additional","affiliation":[{"name":"Department of Cardiology II (Electrophysiology), University Hospital M\u00fcnster, Albert-Schweitzer-Campus 1, M\u00fcnster D-48149, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Eckardt","sequence":"additional","affiliation":[{"name":"Department of Cardiology II (Electrophysiology), University Hospital M\u00fcnster, Albert-Schweitzer-Campus 1, M\u00fcnster D-48149, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1431-9886","authenticated-orcid":false,"given":"Gerrit","family":"Frommeyer","sequence":"additional","affiliation":[{"name":"Department of Cardiology II (Electrophysiology), University Hospital M\u00fcnster, Albert-Schweitzer-Campus 1, M\u00fcnster D-48149, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"key":"2021060815585399800_euaa288-B1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrcardio.2015.110","article-title":"Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms","volume":"13","author":"Frommeyer","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"2021060815585399800_euaa288-B2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s40264-016-0411-3","article-title":"Drug-induced QT\/QTc interval shortening: lessons from drug-induced QT\/QTc prolongation","volume":"39","author":"Malik","year":"2016","journal-title":"Drug Saf"},{"key":"2021060815585399800_euaa288-B3","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1161\/CIRCULATIONAHA.109.894725","article-title":"Drug-induced arrhythmia","volume":"122","author":"Heist","year":"2010","journal-title":"Circulation"},{"key":"2021060815585399800_euaa288-B4","first-page":"263","article-title":"Ventricular tachycardia with 2 variable opposing foci","volume":"59","author":"Dessertenne","year":"1966","journal-title":"Arch Mal Coeur Vaiss"},{"key":"2021060815585399800_euaa288-B5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2125.2012.04415.x","article-title":"Drug-induced QT interval prolongation: does ethnicity of the thorough QT study population matter?","volume":"75","author":"Shah","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"2021060815585399800_euaa288-B6","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2165\/00002018-200528110-00003","article-title":"Drugs, QTc Interval prolongation and final ICH E14 guideline","volume":"28","author":"Shah","year":"2005","journal-title":"Drug Saf"},{"key":"2021060815585399800_euaa288-B7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.vascn.2016.06.002","article-title":"The comprehensive in vitro proarrhythmia assay (CiPA) initiative\u2014update on progress","volume":"81","author":"Colatsky","year":"2016","journal-title":"J Pharmacol Toxicol Methods"},{"key":"2021060815585399800_euaa288-B8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005344-200403000-00007","article-title":"The utility of hERG and repolarization assays in evaluating delayed cardiac repolarization: influence of multi-channel block","volume":"43","author":"Martin","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"2021060815585399800_euaa288-B9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrd.2015.34","article-title":"Evolution of strategies to improve preclinical cardiac safety testing","volume":"15","author":"Gintant","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"2021060815585399800_euaa288-B10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.vascn.2017.04.011","article-title":"Computational modeling for cardiac safety pharmacology analysis: contribution of fibroblasts","volume":"87","author":"Gao","year":"2017","journal-title":"J Pharmacol Toxicol Methods"},{"key":"2021060815585399800_euaa288-B11","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3389\/fphys.2019.01139","article-title":"Three-dimensional heart model-based screening of proarrhythmic potential by in silico simulation of action potential and electrocardiograms","volume":"10","author":"Hwang","year":"2019","journal-title":"Front Physiol"},{"key":"2021060815585399800_euaa288-B12","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.hrthm.2005.12.022","article-title":"Is heart size a factor in ventricular fibrillation? Or how close are rabbit and human hearts?","volume":"3","author":"Panfilov","year":"2006","journal-title":"Heart Rhythm"},{"key":"2021060815585399800_euaa288-B13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.vascn.2004.03.008","article-title":"Review of the predictive value of the Langendorff heart model (Screenit system) in assessing the proarrhythmic potential of drugs","volume":"49","author":"Valentin","year":"2004","journal-title":"J Pharmacol Toxicol Methods"},{"key":"2021060815585399800_euaa288-B14","first-page":"H2477","article-title":"IK of rabbit ventricle is composed of two currents: evidence for IKs","volume":"271","author":"Salata","year":"1996","journal-title":"Am J Physiol"},{"key":"2021060815585399800_euaa288-B15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41569-019-0179-0","article-title":"Animal models of arrhythmia: classic electrophysiology to genetically modified large animals","volume":"16","author":"Clauss","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"2021060815585399800_euaa288-B16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pbiomolbio.2016.05.002","article-title":"Rabbit models as tools for preclinical cardiac electrophysiological safety testing: importance of repolarization reserve","volume":"121","author":"Baczk\u00f3","year":"2016","journal-title":"Prog Biophys Mol Biol"},{"key":"2021060815585399800_euaa288-B17","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/eurheartj\/ehaa251","article-title":"Animals in cardiovascular research: important role of rabbit models in cardiac electrophysiology","volume":"41","author":"Odening","year":"2020","journal-title":"Eur Heart J"},{"key":"2021060815585399800_euaa288-B18","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1113\/JP270526","article-title":"Predicting drug-induced QT prolongation and torsades de pointes","volume":"594","author":"Roden","year":"2016","journal-title":"J Physiol"},{"key":"2021060815585399800_euaa288-B19","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1161\/01.CIR.103.15.2004","article-title":"Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic","volume":"103","author":"Hondeghem","year":"2001","journal-title":"Circulation"},{"key":"2021060815585399800_euaa288-B20","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0735-1097(84)80232-6","article-title":"Long QT: good, bad or indifferent?","volume":"4","author":"Surawicz","year":"1984","journal-title":"J Am Coll Cardiol"},{"key":"2021060815585399800_euaa288-B21","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJMoa1300799","article-title":"Use of azithromycin and death from cardiovascular causes","volume":"368","author":"Svanstr\u00f6m","year":"2013","journal-title":"N Engl J Med"},{"key":"2021060815585399800_euaa288-B22","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa040582","article-title":"Oral erythromycin and the risk of sudden death from cardiac causes","volume":"351","author":"Ray","year":"2004","journal-title":"N Engl J Med"},{"key":"2021060815585399800_euaa288-B23","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1124\/jpet.102.037911","article-title":"Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes","volume":"303","author":"Milberg","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"2021060815585399800_euaa288-B24","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1540-8159.1998.tb00148.x","article-title":"Taking the \u201cidio\u201d out of \u201cidiosyncratic\u201d: predicting torsades de pointes","volume":"21","author":"Roden","year":"1998","journal-title":"Pacing Clin Electrophysiol"},{"key":"2021060815585399800_euaa288-B25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fcvm.2018.00149","article-title":"Recent advances in short QT syndrome","volume":"5","author":"Campuzano","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"2021060815585399800_euaa288-B26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/ncpcardio0097","article-title":"Short QT syndrome: mechanisms, diagnosis and treatment","volume":"2","author":"Bjerregaard","year":"2005","journal-title":"Nat Rev Cardiol"},{"key":"2021060815585399800_euaa288-B27","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/myc.12731","article-title":"Isavuconazole shortens the QTc interval","volume":"61","author":"Mellinghoff","year":"2018","journal-title":"Mycoses"},{"key":"2021060815585399800_euaa288-B28","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-2125.2008.03250.x","article-title":"Lamotrigine does not prolong QTc in a thorough QT\/QTc study in healthy subjects","volume":"66","author":"Dixon","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"2021060815585399800_euaa288-B29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1476-5381.2009.00191.x","article-title":"Drug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives","volume":"159","author":"Shah","year":"2010","journal-title":"Br J Pharmacol"},{"key":"2021060815585399800_euaa288-B30","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/bjp.2008.191","article-title":"Predicting drug-induced changes in QT interval and arrhythmias: QT-shortening drugs point to gaps in the ICHS7B Guidelines","volume":"154","author":"Lu","year":"2008","journal-title":"Br J Pharmacol"},{"key":"2021060815585399800_euaa288-B31","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1161\/01.CIR.0000118177.56908.5B","article-title":"Digitalis administration: an underappreciated but common cause of short QT interval","volume":"109","author":"Cheng","year":"2004","journal-title":"Circulation"},{"key":"2021060815585399800_euaa288-B32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jelectrocard.2006.07.003","article-title":"Is acquired short QT due to digitalis intoxication responsible for malignant ventricular arrhythmias?","volume":"40","author":"Garberoglio","year":"2007","journal-title":"J Electrocardiol"},{"key":"2021060815585399800_euaa288-B33","doi-asserted-by":"crossref","first-page":"e006035","DOI":"10.1161\/JAHA.117.006035","article-title":"Digoxin use and subsequent clinical outcomes in patients with atrial fibrillation with or without heart failure in the ENGAGE AF-TIMI 48 Trial","volume":"6","author":"Eisen","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2021060815585399800_euaa288-B34","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1016\/S0140-6736(14)61836-5","article-title":"Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF","volume":"385","author":"Washam","year":"2015","journal-title":"Lancet"},{"key":"2021060815585399800_euaa288-B35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.amjcard.2018.09.036","article-title":"Meta-analysis of effects of digoxin on survival in patients with atrial fibrillation or heart failure: an update","volume":"123","author":"Vamos","year":"2019","journal-title":"Am J Cardiol"},{"key":"2021060815585399800_euaa288-B36","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1161\/01.CIR.99.9.1265","article-title":"Digitalis","volume":"99","author":"Hauptman","year":"1999","journal-title":"Circulation"},{"key":"2021060815585399800_euaa288-B37","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.hlc.2014.07.074","article-title":"Subcellular mechanisms underlying digitalis-induced arrhythmias: role of calcium\/calmodulin-dependent kinase II (CaMKII) in the transition from an inotropic to an arrhythmogenic effect","volume":"23","author":"Gonano","year":"2014","journal-title":"Heart Lung Circ"},{"key":"2021060815585399800_euaa288-B38","doi-asserted-by":"crossref","first-page":"22A","DOI":"10.1016\/S0735-1097(85)80460-5","article-title":"Cellular electrophysiology of digitalis toxicity","volume":"5","author":"Rosen","year":"1985","journal-title":"J Am Coll Cardiol"},{"key":"2021060815585399800_euaa288-B39","first-page":"100","article-title":"Drug-induced spatial dispersion of repolarization","volume":"15","author":"Antzelevitch","year":"2008","journal-title":"Cardiol J"},{"key":"2021060815585399800_euaa288-B40","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.hrthm.2004.09.011","article-title":"Role of transmural dispersion of repolarization in the genesis of drug-induced torsades de pointes","volume":"2","author":"Antzelevitch","year":"2005","journal-title":"Heart Rhythm"},{"key":"2021060815585399800_euaa288-B41","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.hrthm.2007.05.028","article-title":"Does Tpeak\u2013Tend provide an index of transmural dispersion of repolarization?","volume":"4","author":"Antzelevitch","year":"2007","journal-title":"Heart Rhythm"},{"key":"2021060815585399800_euaa288-B42","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1161\/01.RES.68.6.1729","article-title":"A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle. The M cell","volume":"68","author":"Sicouri","year":"1991","journal-title":"Circ Res"},{"key":"2021060815585399800_euaa288-B43","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1161\/CIRCRESAHA.109.216226","article-title":"M cells in the human heart","volume":"106","author":"Antzelevitch","year":"2010","journal-title":"Circ Res"},{"key":"2021060815585399800_euaa288-B44","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1540-8167.1993.tb01211.x","article-title":"Drug-induced afterdepolarizations and triggered activity occur in a discrete subpopulation of ventricular muscle cells (M cells) in the canine heart: quinidine and digitalis","volume":"4","author":"Sicouri","year":"1993","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2021060815585399800_euaa288-B45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0735-1097(95)00167-X","article-title":"Electrophysiologic characteristics of cells spanning the left ventricular wall of human heart: evidence for presence of M cells","volume":"26","author":"Drouin","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"2021060815585399800_euaa288-B46","doi-asserted-by":"crossref","first-page":"H369","DOI":"10.1152\/ajpheart.1998.275.2.H369","article-title":"Transmural heterogeneity of action potentials and Ito1 in myocytes isolated from the human right ventricle","volume":"275","author":"Li","year":"1998","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2021060815585399800_euaa288-B47","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/CIRCRESAHA.109.204891","article-title":"Transmural dispersion of repolarization in failing and non failing human ventricle","volume":"106","author":"Glukhov","year":"2010","journal-title":"Circ Res"},{"key":"2021060815585399800_euaa288-B48","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/01.CIR.94.8.1981","article-title":"Regional differences in electrophysiological properties of epicardium, midmyocardium, and endocardium: in vitro and in vivo correlations","volume":"94","author":"Anyukhovsky","year":"1996","journal-title":"Circulation"},{"key":"2021060815585399800_euaa288-B49","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1161\/01.CIR.100.21.2184","article-title":"Rate-and site-dependent effects of propafenone, dofetilide, and the new IKs-blocking agent chromanol 293b on individual muscle layers of the intact canine heart","volume":"100","author":"Bauer","year":"1999","journal-title":"Circulation"},{"key":"2021060815585399800_euaa288-B50","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/00005344-200203000-00018","article-title":"Effects of the IKr-blocking agent dofetilide and of the IKs-blocking agent chromanol 293b on regional disparity of left ventricular repolarization in the intact canine heart","volume":"39","author":"Bauer","year":"2002","journal-title":"J Cardiovasc Pharmacol"},{"key":"2021060815585399800_euaa288-B51","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0008-6363(01)00223-1","article-title":"Transmural repolarisation in the left ventricle in humans during normoxia and ischaemia","volume":"50","author":"Taggart","year":"2001","journal-title":"Cardiovasc Res"},{"key":"2021060815585399800_euaa288-B52","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1540-8167.1999.tb00667.x","article-title":"The controversial M cell","volume":"10","author":"Anyukhovsky","year":"1999","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2021060815585399800_euaa288-B53","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0008-6363(99)00061-9","article-title":"Heterogeneous distribution of the two components of delayed rectifier K+ current: a potential mechanism of the proarrhythmic effects of methanesulfonanilideclass III agents","volume":"43","author":"Cheng","year":"1999","journal-title":"Cardiovasc Res"},{"key":"2021060815585399800_euaa288-B54","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00005344-200203000-00002","article-title":"Is the apico-basal gradient larger than the transmural gradient?","volume":"39","author":"de Bakker","year":"2002","journal-title":"J Cardiovasc Pharmacol"},{"key":"2021060815585399800_euaa288-B55","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/hrt.63.6.342","article-title":"QT dispersion: an indication of arrhythmia risk in patients with long QT intervals","volume":"63","author":"Day","year":"1990","journal-title":"Heart"},{"key":"2021060815585399800_euaa288-B56","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1365-2796.2005.01587.x","article-title":"Amplification of spatial dispersion of repolarization underlies sudden cardiac death associated with catecholaminergic polymorphic VT, long QT, short QT and Brugada syndromes","volume":"259","author":"Antzelevitch","year":"2006","journal-title":"J Intern Med"},{"key":"2021060815585399800_euaa288-B57","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12012-019-09543-8","article-title":"Proarrhythmic effect of acetylcholine-esterase inhibitors used in the treatment of Alzheimer\u2019s disease: benefit of rivastigmine in an experimental whole-heart model","volume":"20","author":"Ellermann","year":"2020","journal-title":"Cardiovasc Toxicol"},{"key":"2021060815585399800_euaa288-B58","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/01.fjc.0000129581.81508.78","article-title":"Comparison of the in vitro electrophysiologic and proarrhythmic effects of amiodarone and sotalol in a rabbit model of acute atrioventricular block","volume":"44","author":"Milberg","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"2021060815585399800_euaa288-B59","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/eurjhf\/hfr107","article-title":"A new mechanism preventing proarrhythmia in chronic heart failure: rapid phase-III repolarization explains the low proarrhythmic potential of amiodarone in contrast to sotalol in a model of pacing-induced heart failure","volume":"13","author":"Frommeyer","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2021060815585399800_euaa288-B60","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cardiores.2006.11.025","article-title":"Proarrhythmic electrical remodelling is associated with increased beat-to-beat variability of repolarisation","volume":"73","author":"Thomsen","year":"2007","journal-title":"Cardiovasc Res"},{"key":"2021060815585399800_euaa288-B61","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00395-005-0519-6","article-title":"Sudden cardiac death in dogs with remodeled hearts is associated with larger beat-to-beat variability of repolarization","volume":"100","author":"Thomsen","year":"2005","journal-title":"Basic Res Cardiol"},{"key":"2021060815585399800_euaa288-B62","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1540-8167.1998.tb00130.x","article-title":"Beat-to-beat repolarization lability identifies patients at risk for sudden cardiac death","volume":"9","author":"Atiga","year":"1998","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2021060815585399800_euaa288-B63","doi-asserted-by":"crossref","first-page":"H677","DOI":"10.1152\/ajpheart.2000.278.3.H677","article-title":"Beat-to-beat repolarization variability in ventricular myocytes and its suppression by electrical coupling","volume":"278","author":"Zaniboni","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2021060815585399800_euaa288-B64","doi-asserted-by":"crossref","first-page":"166","DOI":"10.15420\/aer.2019.16.2","article-title":"The increment of short-term variability of repolarisation determines the severity of the imminent arrhythmic outcome","volume":"8","author":"Smoczynska","year":"2019","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"2021060815585399800_euaa288-B65","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1161\/01.CIR.0000145162.64183.C8","article-title":"Increased short-term variability of repolarization predicts d-sotalol\u2013induced torsades de pointes in dogs","volume":"110","author":"Thomsen","year":"2004","journal-title":"Circulation"},{"key":"2021060815585399800_euaa288-B66","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00210-016-1274-y","article-title":"Severe proarrhythmic potential of risperidone compared to quetiapine in an experimental whole-heart model of proarrhythmia","volume":"389","author":"Frommeyer","year":"2016","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"2021060815585399800_euaa288-B67","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/eurheartj\/ehm586","article-title":"Beat-to-beat variability of QT intervals is increased in patients with drug-induced long-QT syndrome: a case control pilot study","volume":"29","author":"Hinterseer","year":"2007","journal-title":"Eur Heart J"},{"key":"2021060815585399800_euaa288-B68","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.amjcard.2010.02.033","article-title":"Usefulness of short-term variability of QT intervals as a predictor for electrical remodeling and proarrhythmia in patients with nonischemic heart failure","volume":"106","author":"Hinterseer","year":"2010","journal-title":"Am J Cardiol"},{"key":"2021060815585399800_euaa288-B69","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1152\/physrev.00002.2005","article-title":"Molecular physiology of cardiac repolarization","volume":"85","author":"Nerbonne","year":"2005","journal-title":"Physiol Rev"},{"key":"2021060815585399800_euaa288-B70","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1540-8167.2003.02466.x","article-title":"Detection of proarrhythmia in the female rabbit heart: blinded validation","volume":"14","author":"Hondeghem","year":"2003","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2021060815585399800_euaa288-B71","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00005344-200301000-00003","article-title":"Blinded test in isolated female rabbit heart reliably identifies action potential duration prolongation and proarrhythmic drugs: importance of triangulation, reverse use dependence, and instability","volume":"41","author":"Hondeghem","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"2021060815585399800_euaa288-B72","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0008-6363(01)00259-0","article-title":"Phase 2 prolongation, in the absence of instability and triangulation, antagonizes class III proarrhythmia","volume":"50","author":"Hondeghem","year":"2001","journal-title":"Cardiovasc Res"},{"key":"2021060815585399800_euaa288-B73","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/FJC.0b013e3182135e91","article-title":"Drug-induced QTC prolongation dangerously underestimates proarrhythmic potential: lessons from terfenadine","volume":"57","author":"Hondeghem","year":"2011","journal-title":"J Cardiovasc Pharmacol"},{"key":"2021060815585399800_euaa288-B74","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1540-8167.1999.tb00673.x","article-title":"The molecular and ionic specificity of antiarrhythmic drug actions","volume":"10","author":"Nattel","year":"1999","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2021060815585399800_euaa288-B75","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1254\/jphs.CPJ06001X","article-title":"Cardiac myocytes Ca2+ and Na+ regulation in normal and failing hearts","volume":"100","author":"Bers","year":"2006","journal-title":"J Pharmacol Sci"},{"key":"2021060815585399800_euaa288-B76","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.pbiomolbio.2009.01.009","article-title":"Voltage-gated Na+ channel transcript patterns in the mammalian heart are species-dependent","volume":"98","author":"Blechschmidt","year":"2008","journal-title":"Prog Biophys Mol Biol"},{"key":"2021060815585399800_euaa288-B77","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fphar.2012.00006","article-title":"Cardiac safety implications of hNav1. 5 blockade and a framework for pre-clinical evaluation","volume":"3","author":"Erdemli","year":"2012","journal-title":"Front Pharmacol"},{"key":"2021060815585399800_euaa288-B78","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1111\/bph.15098","article-title":"Transgenic LQT2, LQT5 and LQT2-5 rabbit models with decreased repolarisation reserve for prediction of drug-induced ventricular arrhythmias","volume":"177","author":"Hornyik","year":"2020","journal-title":"Br J Pharmacol"},{"key":"2021060815585399800_euaa288-B79","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1515\/jbcpp-2016-0110","article-title":"Isolated heart models for studying cardiac electrophysiology: a historical perspective and recent advances","volume":"28","author":"Yeo","year":"2017","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"2021060815585399800_euaa288-B80","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s00399-013-0260-z","article-title":"The ECG in cardiovascular-relevant animal models of electrophysiology","volume":"24","author":"Kaese","year":"2013","journal-title":"Herzschr Elektrophys"},{"key":"2021060815585399800_euaa288-B81","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0008-6363(98)00043-1","article-title":"Experimental models of torsade de pointes","volume":"39","author":"Eckardt","year":"1998","journal-title":"Cardiovasc Res"},{"key":"2021060815585399800_euaa288-B82","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1365-2796.2005.01590.x","article-title":"In vitro and in vivo models for testing arrhythmogenesis in drugs","volume":"259","author":"Carlsson","year":"2006","journal-title":"J Intern Med"},{"key":"2021060815585399800_euaa288-B83","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1161\/01.CIR.103.23.2851","article-title":"Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome: direct evidence from intracellular recordings in the intact left ventricular wall","volume":"103","author":"Yan","year":"2001","journal-title":"Circulation"},{"key":"2021060815585399800_euaa288-B84","first-page":"1244","article-title":"Fluconazole-induced long QT syndrome via impaired human ether-a-go-go-related gene (hERG) protein trafficking in rabbits","volume":"19","author":"Wang","year":"2017","journal-title":"Europace"},{"key":"2021060815585399800_euaa288-B85","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.vascn.2016.06.006","article-title":"Assessment of drug-induced proarrhythmia: the importance of study design in the rabbit left ventricular wedge model","volume":"81","author":"Lu","year":"2016","journal-title":"J Pharmacol Toxicol Methods"},{"key":"2021060815585399800_euaa288-B86","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF01812150","article-title":"Untersuchungen am \u00fcberlebenden S\u00e4ugethierherzen","volume":"61","author":"Langendorff","year":"1895","journal-title":"Pfl\u00fcgers Arch"},{"key":"2021060815585399800_euaa288-B87","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pbiomolbio.2016.05.006","article-title":"Technical advances in studying cardiac electrophysiology\u2013role of rabbit models","volume":"121","author":"Kang","year":"2016","journal-title":"Prog Biophys Mol Biol"},{"key":"2021060815585399800_euaa288-B88","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/hrt.48.3.213","article-title":"\u201cTorsade de pointes\u201d tachycardia. Re-entry or focal activity?","volume":"48","author":"D\u2019Alnoncourt","year":"1982","journal-title":"Br Heart J"},{"key":"2021060815585399800_euaa288-B89","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1540-8167.1997.tb01001.x","article-title":"Electrophysiologic features of torsades de pointes: insights from a new isolated rabbit heart model","volume":"8","author":"Zabel","year":"1997","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2021060815585399800_euaa288-B90","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00005344-199809000-00013","article-title":"Drug-related torsades de pointes in the isolated rabbit heart: comparison of clofilium, d, l-sotalol, and erythromycin","volume":"32","author":"Eckardt","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"key":"2021060815585399800_euaa288-B91","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1089\/jwh.1998.7.547","article-title":"Female gender as a risk factor for drug-induced cardiac arrhythmias: evaluation of clinical and experimental evidence","volume":"7","author":"Ebert","year":"1998","journal-title":"J Womens Health"},{"key":"2021060815585399800_euaa288-B92","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1046\/j.1540-8167.2001.00538.x","article-title":"Female gender is a risk factor for drug-induced long QT and cardiac arrhythmias in an in vivo rabbit model","volume":"12","author":"Lu","year":"2001","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2021060815585399800_euaa288-B93","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/europace\/eux383","article-title":"Antiarrhythmic effect of antazoline in experimental models of acquired short-and long-QT-syndromes","volume":"20","author":"Ellermann","year":"2018","journal-title":"Europace"},{"key":"2021060815585399800_euaa288-B94","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0735-1097(96)00588-8","article-title":"Optical mapping of drug-induced polymorphic arrhythmias and torsade de pointes in the isolated rabbit heart","volume":"29","author":"Asano","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"2021060815585399800_euaa288-B95","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0008-6363(00)00119-X","article-title":"The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications: report on a Policy Conference of the European Society of Cardiology","volume":"47","author":"Haverkamp","year":"2000","journal-title":"Cardiovasc Res"},{"key":"2021060815585399800_euaa288-B96","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1540-8159.1991.tb02841.x","article-title":"Bradycardia-dependent early afterdepolarizations in a patient with QTU prolongation and torsade de pointes in association with marked bradycardia and hypokalemia","volume":"14","author":"Shimizu","year":"1991","journal-title":"Pacing Clin Electrophysiol"},{"key":"2021060815585399800_euaa288-B97","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/01.CIR.93.3.407","article-title":"Extracellular potassium modulation of drug block of IKr: implications for torsade de pointes and reverse use-dependence","volume":"93","author":"Yang","year":"1996","journal-title":"Circulation"},{"key":"2021060815585399800_euaa288-B98","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s003950050073","article-title":"Clofilium in the isolated perfused rabbit heart: a new model to study proarrhythmia induced by class III antiarrhythmic drugs","volume":"93","author":"Johna","year":"1998","journal-title":"Basic Res Cardiol"},{"key":"2021060815585399800_euaa288-B99","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/sj.bjp.0707297","article-title":"Combined pharmacological block of IKr and IKs increases short-term QT interval variability and provokes torsades de pointes","volume":"151","author":"Lengyel","year":"2009","journal-title":"Br J Pharmacol"},{"key":"2021060815585399800_euaa288-B100","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cardiores.2004.10.016","article-title":"Transmural dispersion of repolarization as a key factor of arrhythmogenicity in a novel intact heart model of LQT3","volume":"65","author":"Milberg","year":"2005","journal-title":"Cardiovasc Res"},{"key":"2021060815585399800_euaa288-B101","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1540-8167.2009.01469.x","article-title":"Mode of induction of ventricular tachycardia and prognosis in patients with coronary disease: the Multicenter UnSustained Tachycardia Trial (MUSTT)","volume":"20","author":"Piccini","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2021060815585399800_euaa288-B102","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/CIRCULATIONAHA.115.017885","article-title":"Programmed ventricular stimulation for risk stratification in the Brugada syndrome: a pooled analysis","volume":"133","author":"Sroubek","year":"2016","journal-title":"Circulation"},{"key":"2021060815585399800_euaa288-B103","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.hrthm.2008.01.022","article-title":"Cellular basis for arrhythmogenesis in an experimental model of the SQT1 form of the short QT syndrome","volume":"5","author":"Patel","year":"2008","journal-title":"Heart Rhythm"},{"key":"2021060815585399800_euaa288-B104","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/jce.13029","article-title":"Ranolazine and vernakalant prevent ventricular arrhythmias in an experimental whole-heart model of short QT syndrome","volume":"27","author":"Frommeyer","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2021060815585399800_euaa288-B105","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ijcard.2016.11.251","article-title":"Experimental evidence for a severe proarrhythmic potential of levosimendan","volume":"228","author":"Frommeyer","year":"2017","journal-title":"Int J Cardiol"},{"key":"2021060815585399800_euaa288-B106","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/bcpt.12829","article-title":"Ivabradine reduces digitalis-induced ventricular arrhythmias","volume":"121","author":"Frommeyer","year":"2017","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2021060815585399800_euaa288-B107","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s12012-018-9494-7","article-title":"Digitalis promotes ventricular arrhythmias in flecainide-and ranolazine-pretreated hearts","volume":"19","author":"Ellermann","year":"2019","journal-title":"Cardiovasc Toxicol"},{"key":"2021060815585399800_euaa288-B108","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0706894","article-title":"A rabbit Langendorff heart proarrhythmia model: predictive value for clinical identification of Torsades de Pointes","volume":"149","author":"Lawrence","year":"2006","journal-title":"Br J Pharmacol"},{"key":"2021060815585399800_euaa288-B109","doi-asserted-by":"crossref","first-page":"H643","DOI":"10.1152\/ajpheart.00074.2010","article-title":"Electrophysiological studies of transgenic long QT type 1 and type 2 rabbits reveal genotype-specific differences in ventricular refractoriness and His conduction","volume":"299","author":"Odening","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2021060815585399800_euaa288-B110","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00005344-199008000-00014","article-title":"QTU-prolongation and torsades de pointes induced by putative class III antiarrhythmic agents in the rabbit: etiology and interventions","volume":"16","author":"Carlsson","year":"1990","journal-title":"J Cardiovasc Pharmacol"},{"key":"2021060815585399800_euaa288-B111","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.vascn.2008.05.126","article-title":"Development of a conscious rabbit telemetry model for chronic monitoring of blood pressure, ECG and temperature","volume":"58","author":"D'Aubioul","year":"2008","journal-title":"J Pharmacol Toxicol Methods"},{"key":"2021060815585399800_euaa288-B112","first-page":"231","article-title":"Rhythm anomalies related to delayed repolarization in vivo: influence of sarcolemmal Ca++ entry and intracellular Ca++ overload","volume":"279","author":"Carlsson","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"2021060815585399800_euaa288-B113","doi-asserted-by":"crossref","first-page":"H2264","DOI":"10.1152\/ajpheart.00680.2008","article-title":"Pharmacogenomics of anesthetic drugs in transgenic LQT1 and LQT2 rabbits reveal genotype-specific differential effects on cardiac repolarization","volume":"295","author":"Odening","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2021060815585399800_euaa288-B114","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1111\/bph.13870","article-title":"The anaesthetized rabbit with acute atrioventricular block provides a new model for detecting drug-induced Torsade de Pointes","volume":"174","author":"Hagiwara","year":"2017","journal-title":"Br J Pharmacol"},{"key":"2021060815585399800_euaa288-B115","first-page":"2246","article-title":"Mechanisms of cardiac arrhythmias and sudden death in transgenic rabbits with long QT syndrome","volume":"118","author":"Brunner","year":"2008","journal-title":"J Clin Invest"},{"key":"2021060815585399800_euaa288-B116","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pbiomolbio.2016.05.004","article-title":"Transgenic rabbit models to investigate the cardiac ion channel disease long QT syndrome","volume":"121","author":"Lang","year":"2016","journal-title":"Prog Biophys Mol Biol"},{"key":"2021060815585399800_euaa288-B117","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1111\/bph.13500","article-title":"A novel transgenic rabbit model with reduced repolarization reserve: long QT syndrome caused by a dominant-negative mutation of the KCNE1 gene","volume":"173","author":"Major","year":"2016","journal-title":"Br J Pharmacol"},{"key":"2021060815585399800_euaa288-B118","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.vascn.2006.05.006","article-title":"Isolated heart perfusion according to Langendorff\u2014still viable in the new millennium","volume":"55","author":"Skrzypiec-Spring","year":"2007","journal-title":"J Pharmacol Toxicol Methods"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/23\/6\/828\/38533736\/euaa288.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/23\/6\/828\/38533736\/euaa288.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T16:43:38Z","timestamp":1623170618000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/23\/6\/828\/5983831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":118,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,11,17]]},"published-print":{"date-parts":[[2021,6,7]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euaa288","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,1]]},"published":{"date-parts":[[2020,11,17]]}}}